However, robust ERK1/2 inhibition by small molecule inhibitors or RKIP (unphosphorylated RKIPS153A), although potentially effective against cancer, also leads to the apoptosis of cardiomyocytes, cells with very limited regeneration capacity. This evidence concerns the gene MAPK3 and cancer.